718 related articles for article (PubMed ID: 23977848)
1. An inhibitor of NADPH oxidase-4 attenuates established pulmonary fibrosis in a rodent disease model.
Jarman ER; Khambata VS; Cope C; Jones P; Roger J; Ye LY; Duggan N; Head D; Pearce A; Press NJ; Bellenie B; Sohal B; Jarai G
Am J Respir Cell Mol Biol; 2014 Jan; 50(1):158-69. PubMed ID: 23977848
[TBL] [Abstract][Full Text] [Related]
2. Nox4 mediates hypoxia-stimulated myofibroblast differentiation in nasal polyp-derived fibroblasts.
Moon YM; Kang HJ; Cho JS; Park IH; Lee HM
Int Arch Allergy Immunol; 2012; 159(4):399-409. PubMed ID: 22846744
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor β1 (TGFβ1)-induced CD44V6-NOX4 signaling in pathogenesis of idiopathic pulmonary fibrosis.
Ghatak S; Hascall VC; Markwald RR; Feghali-Bostwick C; Artlett CM; Gooz M; Bogatkevich GS; Atanelishvili I; Silver RM; Wood J; Thannickal VJ; Misra S
J Biol Chem; 2017 Jun; 292(25):10490-10519. PubMed ID: 28389561
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor (TGF)-β1-induced miR-133a inhibits myofibroblast differentiation and pulmonary fibrosis.
Wei P; Xie Y; Abel PW; Huang Y; Ma Q; Li L; Hao J; Wolff DW; Wei T; Tu Y
Cell Death Dis; 2019 Sep; 10(9):670. PubMed ID: 31511493
[TBL] [Abstract][Full Text] [Related]
5. Targeting of NADPH oxidase in vitro and in vivo suppresses fibroblast activation and experimental skin fibrosis.
Dosoki H; Stegemann A; Taha M; Schnittler H; Luger TA; Schröder K; Distler JH; Kerkhoff C; Böhm M
Exp Dermatol; 2017 Jan; 26(1):73-81. PubMed ID: 27576129
[TBL] [Abstract][Full Text] [Related]
6. Metformin attenuates lung fibrosis development via NOX4 suppression.
Sato N; Takasaka N; Yoshida M; Tsubouchi K; Minagawa S; Araya J; Saito N; Fujita Y; Kurita Y; Kobayashi K; Ito S; Hara H; Kadota T; Yanagisawa H; Hashimoto M; Utsumi H; Wakui H; Kojima J; Numata T; Kaneko Y; Odaka M; Morikawa T; Nakayama K; Kohrogi H; Kuwano K
Respir Res; 2016 Aug; 17(1):107. PubMed ID: 27576730
[TBL] [Abstract][Full Text] [Related]
7. The hedgehog system machinery controls transforming growth factor-β-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis.
Cigna N; Farrokhi Moshai E; Brayer S; Marchal-Somme J; Wémeau-Stervinou L; Fabre A; Mal H; Lesèche G; Dehoux M; Soler P; Crestani B; Mailleux AA
Am J Pathol; 2012 Dec; 181(6):2126-37. PubMed ID: 23031257
[TBL] [Abstract][Full Text] [Related]
8. Role of reactive oxygen species in transforming growth factor beta1-induced alpha smooth-muscle actin and collagen production in nasal polyp-derived fibroblasts.
Park IH; Park SJ; Cho JS; Moon YM; Kim TH; Lee SH; Lee HM
Int Arch Allergy Immunol; 2012; 159(3):278-86. PubMed ID: 22722757
[TBL] [Abstract][Full Text] [Related]
9. NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFbeta1-induced fibroblast differentiation into myofibroblasts.
Amara N; Goven D; Prost F; Muloway R; Crestani B; Boczkowski J
Thorax; 2010 Aug; 65(8):733-8. PubMed ID: 20685750
[TBL] [Abstract][Full Text] [Related]
10. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor-1 promotes the proliferation and inhibits the apoptosis of pulmonary fibroblasts by Ca(2+) signaling.
Zhang YP; Wang WL; Liu J; Li WB; Bai LL; Yuan YD; Song SX
Thromb Res; 2013 Jan; 131(1):64-71. PubMed ID: 23021499
[TBL] [Abstract][Full Text] [Related]
12. Human antigen R promotes lung fibroblast differentiation to myofibroblasts and increases extracellular matrix production.
Al-Habeeb F; Aloufi N; Traboulsi H; Liu X; Nair P; Haston C; Azuelos I; Huang SK; White ES; Gallouzi IE; Di Marco S; Eidelman DH; Baglole CJ
J Cell Physiol; 2021 Oct; 236(10):6836-6851. PubMed ID: 33855709
[TBL] [Abstract][Full Text] [Related]
13. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis.
Liu G; Friggeri A; Yang Y; Milosevic J; Ding Q; Thannickal VJ; Kaminski N; Abraham E
J Exp Med; 2010 Aug; 207(8):1589-97. PubMed ID: 20643828
[TBL] [Abstract][Full Text] [Related]
14. Substrate stiffness influences TGF-β1-induced differentiation of bronchial fibroblasts into myofibroblasts in airway remodeling.
Shi Y; Dong Y; Duan Y; Jiang X; Chen C; Deng L
Mol Med Rep; 2013 Feb; 7(2):419-24. PubMed ID: 23229284
[TBL] [Abstract][Full Text] [Related]
15. Fluorofenidone attenuates TGF-β1-induced lung fibroblast activation via restoring the expression of caveolin-1.
Liu J; Song C; Xiao Q; Hu G; Tao L; Meng J
Shock; 2015 Feb; 43(2):201-7. PubMed ID: 25394239
[TBL] [Abstract][Full Text] [Related]
16. Lysocardiolipin acyltransferase regulates TGF-β mediated lung fibroblast differentiation.
Huang LS; Jiang P; Feghali-Bostwick C; Reddy SP; Garcia JGN; Natarajan V
Free Radic Biol Med; 2017 Nov; 112():162-173. PubMed ID: 28751023
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
[TBL] [Abstract][Full Text] [Related]
18. The inhibitory effect of ginsan on TGF-β mediated fibrotic process.
Ahn JY; Kim MH; Lim MJ; Park S; Lee SL; Yun YS; Song JY
J Cell Physiol; 2011 May; 226(5):1241-7. PubMed ID: 20945375
[TBL] [Abstract][Full Text] [Related]
19. Cysteine-rich protein 1 is regulated by transforming growth factor-β1 and expressed in lung fibrosis.
Järvinen PM; Myllärniemi M; Liu H; Moore HM; Leppäranta O; Salmenkivi K; Koli K; Latonen L; Band AM; Laiho M
J Cell Physiol; 2012 Jun; 227(6):2605-12. PubMed ID: 21882188
[TBL] [Abstract][Full Text] [Related]
20. Azithromycin attenuates myofibroblast differentiation and lung fibrosis development through proteasomal degradation of NOX4.
Tsubouchi K; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Sato N; Yoshida M; Kurita Y; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Nakanishi Y; Kuwano K
Autophagy; 2017 Aug; 13(8):1420-1434. PubMed ID: 28613983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]